MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$295K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from promissory note, n...
Deferred tax asset
Gain on sale of assets, net of c...
Others
Negative Cash Flow Breakdown
Net income (loss)
Accrued liabilities
Income tax payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-1,247
6,340
-8,887
-4,753
Gain on sale of assets, net of cash
-252
15,563
-
-
Depreciation and amortization
134
0
1,496
952
Stock-based compensation (309 from continuing and 93 from discontinued operations for 2026 and all from discontinued operations for 2025-see note 8)
98
304
159
166
Amortization of debt discount and issuance costs
-
43
-
-
Release of customer allowance liability
-
0
-778
61
Loss on remeasurement of derivative liability
11
227
-
-
Gain on extinguishment of debt
191
-
-161
-
Impairment of contract fulfillment assets
-
-
984
0
Other
-
0
-243
-79
Investment income from dna x llc under the equity method
0
48
-
-
Accounts receivable
0
-250
1,813
628
Deferred tax assets
-
-1,364
-
-
Non-trade receivable
-94
0
3,161
2,874
Deferred tax liability
0
600
-
-
Deferred tax asset
1,364
-
-
-
Inventory
0
-5,490
0
-181
Inventory
-
-
-3,831
968
Prepaid expenses and other current assets
151
-1,663
-1,303
-1,400
Contract fulfillment assets
0
-129
4,984
6,330
Other assets
-29
103
4
-1
Accounts payable
-19
-2,653
11,971
-175
Accrued liabilities
-721
-1,288
-1,932
1,407
Deferred tax assets
-
-
1,377
-
Income tax payable
-247
-221
784
64
Net cash used in operating activities
-2,001
-3,466
-2,004
-7,034
Net cash received from asset sale
0
3,358
-
-
Additions to identifiable intangibles - software assets
94
-
-
-
Proceeds from issuance of common stock, net of issuance costs
-
0
-126
4,845
Net cash provided by investing activities
-94
3,358
-
-
Proceeds from promissory note, net of issuance costs
1,800
0
1,260
2,320
Repayments of short-term borrowings
-
-
-
0
Proceeds (payments) from short-term borrowings
-
-
-555
-
Proceeds from short-term borrowings
-
0
-
-
Net cash provided by financing activities
1,800
0
1,170
7,165
Net decrease in cash and cash equivalents
-295
-108
-834
131
Cash and cash equivalents at beginning of period
1,195
1,303
2,137
5,343
Cash and cash equivalents at end of period
900
1,195
1,303
2,137
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from promissory
note, net of issuance...
$1,800K
(-35.48%↓ Y/Y)
Net cash provided by
financing activities
$1,800K
(-83.86%↓ Y/Y)
Net decrease in cash
and cash...
-$295K
(91.16%↑ Y/Y)
Canceled cashflow
$1,800K
Deferred tax asset
$1,364K
Gain on sale of
assets, net of cash
-$252K
Depreciation and
amortization
$134K
(-92.76%↓ Y/Y)
Stock-based compensation
(309 from continuing...
$98K
(-91.94%↓ Y/Y)
Non-trade receivable
-$94K
(38.16%↑ Y/Y)
Other assets
-$29K
(-261.11%↓ Y/Y)
Loss on
remeasurement of derivative...
$11K
Net cash used in
operating activities
-$2,001K
(86.19%↑ Y/Y)
Canceled cashflow
$1,982K
Net cash provided by
investing activities
-$94K
something is missing
-$1,407K
Net income (loss)
-$1,247K
(82.23%↑ Y/Y)
Accrued liabilities
-$721K
(49.69%↑ Y/Y)
Income tax payable
-$247K
(-584.31%↓ Y/Y)
Gain on
extinguishment of debt
$191K
Prepaid expenses and
other current assets
$151K
(-74.36%↓ Y/Y)
Accounts payable
-$19K
(99.16%↑ Y/Y)
Additions to identifiable
intangibles - software...
$94K
Buy us a coffee
DNA X, Inc. (SONM)
DNA X, Inc. (SONM)